Back to IMGNView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
1
Historical Events
0
Regulatory Approvals
Competitive Landscape
4 competitors in Endometrial Cancer
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Pegylated Liposomal DoxorubicinPhase 3
Epithelial Ovarian Cancer
Single high dose of liposomal amphotericin BPhase 3
Disseminated Histoplasma Capsulatum Infection
Mirvetuximab SoravtansinePhase 3
Epithelial Ovarian Cancer
BB-10901Phase 2
Small Cell Lung Cancer
Sterile waterPhase 2
HIV I Infection
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts